G or EPAM: Which Is the Better Value Stock Right Now?

Core Viewpoint - The article compares Genpact (G) and Epam (EPAM) to determine which stock is more attractive to value investors, highlighting the importance of various valuation metrics in this assessment [1]. Group 1: Valuation Metrics - Genpact has a forward P/E ratio of 12.12, while Epam has a forward P/E of 17.40, indicating that Genpact may be undervalued compared to Epam [5]. - Genpact's PEG ratio is 1.26, which is lower than Epam's PEG ratio of 2.13, suggesting that Genpact offers better value when considering expected earnings growth [5]. - Genpact has a P/B ratio of 3.25, slightly lower than Epam's P/B of 3.26, further supporting the argument that Genpact is a more attractive value option [6]. Group 2: Earnings Outlook - Both Genpact and Epam hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and improving earnings outlooks for both companies [3]. - Despite the positive earnings outlook for both companies, value investors will focus on traditional figures and metrics to assess undervaluation [3]. Group 3: Value Grades - Genpact has earned a Value grade of A, while Epam has a Value grade of C, reinforcing the conclusion that Genpact is the superior value option at this time [6].